Development of Q-LAAD, an allonamer-based antigen test for the rapid detection of SARS-CoV-2

Elise Overgaard, Shiwei Li, Hunter J. Covert, Ken Tawara, Aidan M. Poe, N. Hagan Shults, Aliona A. Chernish, Brandi Sweet, Cara R. Gonzales, Clémentine F.N. Gibard, Steven J. Burden
doi: https://doi.org/10.1101/2022.09.23.22280297

Article Information

doi 
https://doi.org/10.1101/2022.09.23.22280297
History 
  • September 25, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Elise Overgaard1,
  2. Shiwei Li2,
  3. Hunter J. Covert2,
  4. Ken Tawara2,
  5. Aidan M. Poe2,
  6. N. Hagan Shults2,
  7. Aliona A. Chernish2,
  8. Brandi Sweet2,
  9. Cara R. Gonzales2,
  10. Clémentine F.N. Gibard2 and
  11. Steven J. Burden2,*
  1. 1Boise State University, Biomolecular Sciences Graduate Program, Boise, ID, 83725
  2. 2Facible Biodiagnostics, LLC, Meridian, ID, 83642
  1. ↵*Correspondence: Steven.Burden{at}Facible.com
Back to top
Posted September 25, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Development of Q-LAAD, an allonamer-based antigen test for the rapid detection of SARS-CoV-2
Elise Overgaard, Shiwei Li, Hunter J. Covert, Ken Tawara, Aidan M. Poe, N. Hagan Shults, Aliona A. Chernish, Brandi Sweet, Cara R. Gonzales, Clémentine F.N. Gibard, Steven J. Burden
medRxiv 2022.09.23.22280297; doi: https://doi.org/10.1101/2022.09.23.22280297
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area